India Globalization Capital, Inc. (IGCC)


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In India Globalization Capital, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in India Globalization Capital, Inc. (“India Globalization” or the “Company”) (formerly, NYSE:IGC) (Other OTC:IGCC) of the January 2, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in India Globalization stock or options between October 25, 2017 and October 29, 2018 and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

The lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all those who purchased India Globalization securities between October 25, 2017 and October 28, 2018 (the “Class Period”).  The case, Samn v. India Globalization Technology et al, No. 18-cv-06199 was filed on November 2, 2018.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) India Globalization’s business model was in a state of change in order to lure potential blockchain and cannabis investors; (2) India Globalization had overstated the benefits of its relationships with manufacturers, partners, and distributors in order to inflate the Company’s potential commercial success in the blockchain and cannabis markets; (3) as a result, the New York Stock Exchange (“NYSE”) delisted India Globalization’s shares from their exchange; and (4) consequently, Defendants’ statements about India Globalization’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Specifically, on October 4, 2018, MarketWatch published an article which detailed the suspicious nature of India Globalization’s public statements regarding the Company’s cannabis-infused energy drink business initiatives, its ability to utilize a Malaysian manufacturer to transition into producing cannabis-infused energy drinks, and its partnerships with both Dama Pharma and a German distributor. 

On this news, the Company’s stock price fell from $6.41 per share on October 4, 2018 to $4.05 per share on October 5, 2018—a $2.36 or 36.72% drop.

Then, on October 29, 2018, the NYSE announced that the delisting process would commence for India Globalization’s stock traded on its exchange. The delisting process was initiated at least in part because the NYSE found that the Company had “substantially discontinued the business that it conducted at the time it was listed or admitted to trading.”

On this news, shares of India Globalization were halted.

On the next day, October 30, 2018, shares of India Globalization began trading under the ticker symbol “IGCC.” The stock price fell from $2.49 per share on October 26, 2018 to $0.56 per share on October 30, 2018—a $1.93 or 77.5% drop.

Contact us

India Globalization Capital, Inc. (IGCC)

Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.

Details

Filed on 11/05/2018

Ticker OtherOTC:IGCC

Office

685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331

Counsel

Richard W. Gonnello rgonnello@faruqilaw.com Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania